Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people
Authors
Keywords
-
Journal
HEART
Volume -, Issue -, Pages heartjnl-2020-317393
Publisher
BMJ
Online
2020-08-01
DOI
10.1136/heartjnl-2020-317393
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tobacco Smoking Increases the Lung Gene Expression of ACE2, the Receptor of SARS-CoV-2
- (2020) Guoshuai Cai et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19
- (2020) Peng Zhang et al. CIRCULATION RESEARCH
- Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
- (2020) Safiya Richardson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Ethnicity and COVID-19: an urgent public health research priority
- (2020) Manish Pareek et al. LANCET
- Hopes rise for coronavirus drug remdesivir
- (2020) Heidi Ledford NATURE
- Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19
- (2020) Mandeep R. Mehra et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
- (2020) Muthiah Vaduganathan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020
- (2020) et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020
- (2020) Shikha Garg et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19)
- (2020) Neil Mehta et al. JAMA Cardiology
- Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China
- (2020) Juyi Li et al. JAMA Cardiology
- Clinical presentation and initial management critically ill patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Brescia, Italy
- (2020) Simone Piva et al. JOURNAL OF CRITICAL CARE
- Anticholinergic Drug Exposure and the Risk of Dementia
- (2019) Carol A. C. Coupland et al. JAMA Internal Medicine
- Admission patterns and survival from status epilepticus in critical care in the UK: an analysis of the Intensive Care National Audit and Research Centre Case Mix Programme database
- (2019) M. S. Damian et al. EUROPEAN JOURNAL OF NEUROLOGY
- Spatial distribution of clinical computer systems in primary care in England in 2016 and implications for primary care electronic medical record databases: a cross-sectional population study
- (2018) Evangelos Kontopantelis et al. BMJ Open
- Development and validation of the new ICNARC model for prediction of acute hospital mortality in adult critical care
- (2017) Paloma Ferrando-Vivas et al. JOURNAL OF CRITICAL CARE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search